Brief: Indaptus Therapeutics Announces Initiation Of First-In-Human, Open Label, Dose Escalation And Expansion Phase 1 Trial Of Decoy20 In Patients With Advanced Solid Tumors

Indaptus Therapeutics

13/12/2022 12:46

Dec 13 (Reuters) - Indaptus Therapeutics Inc  INDP.O :
    * INDAPTUS THERAPEUTICS ANNOUNCES INITIATION OF
FIRST-IN-HUMAN,
OPEN LABEL, DOSE ESCALATION AND EXPANSION MULTICENTER PHASE 1
CLINICAL TRIAL OF DECOY20 IN PATIENTS WITH ADVANCED SOLID TUMORS

Source text for Eikon:  ID:nGNXb3z4zk 
Further company coverage:  INDP.O 
 ((Reuters.Briefs@thomsonreuters.com;))